Literature DB >> 25267911

Sumatriptan plus naproxen for acute migraine headaches in adults.

Simon Law1, Sheena Derry1, R Andrew Moore1.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of the review will be to determine the efficacy and tolerability of sumatriptan plus naproxen, administered together as separate agents or taken as a fixed-dose combination tablet, compared to placebo and other active interventions in the treatment of acute migraine headaches in adults.

Entities:  

Year:  2010        PMID： 25267911      PMCID： PMC4176624          DOI： 10.1002/14651858.CD008541

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  31 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  Impact of covert duplicate publication on meta-analysis: a case study.

Authors:  M R Tramèr; D J Reynolds; R A Moore; H J McQuay
Journal:  BMJ       Date:  1997-09-13

Review 3.  Burden of migraine. A review of its socioeconomic impact.

Authors:  G D Solomon; K L Price
Journal:  Pharmacoeconomics       Date:  1997       Impact factor: 4.981

4.  Changes in resource use and outcomes for patients with migraine treated with sumatriptan: a managed care perspective.

Authors:  J H Lofland; N E Johnson; A S Batenhorst; D B Nash
Journal:  Arch Intern Med       Date:  1999-04-26

5.  Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study.

Authors:  Seymour Diamond; Marcelo E Bigal; Stephen Silberstein; Elizabeth Loder; Michael Reed; Richard B Lipton
Journal:  Headache       Date:  2007-03       Impact factor: 5.887

6.  The number needed to treat: a clinically useful measure of treatment effect.

Authors:  R J Cook; D L Sackett
Journal:  BMJ       Date:  1995-02-18

7.  Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Authors:  M D Ferrari; P J Goadsby; K I Roon; R B Lipton
Journal:  Cephalalgia       Date:  2002-10       Impact factor: 6.292

8.  Prevalence and burden of headache and migraine in Germany.

Authors:  Andrea Radtke; Hannelore Neuhauser
Journal:  Headache       Date:  2009-01       Impact factor: 5.887

9.  Improvements in health-related quality of life with sumatriptan treatment for migraine.

Authors:  P Jhingran; R K Cady; J Rubino; D Miller; R B Grice; D L Gutterman
Journal:  J Fam Pract       Date:  1996-01       Impact factor: 0.493

10.  Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.

Authors:  Marcelo E Bigal; Daniel Serrano; Michael Reed; Richard B Lipton
Journal:  Neurology       Date:  2008-08-19       Impact factor: 9.910
View more
  1 in total

Review 1.  Sumatriptan (oral route of administration) for acute migraine attacks in adults.

Authors:  Christopher J Derry; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.